Updates for 2023
FDLI remains committed to providing high-quality educational programs while keeping our members and event attendees safe during the current pandemic. With this in mind, we are excited to announce that the 2023 Legal and Practical Issues in Cannabis Regulation Conference will be a hybrid event. Please know we are actively exploring options to ensure an engaging and enjoyable experience. Be sure to check the course website regularly for additional announcements and updates.
The cannabis and cannabis-derived products market continues to grow with increasing legalization at the state level. However, laws and regulations can vary greatly from state to state, and the future outlook remains murky at the federal level. This conference will examine the present and proposed regulatory schemes and concerns for this unique industry that impacts many FDA regulated product categories. Experts from across the country and abroad will also discuss practical concerns for entities attempting to navigate this continually evolving legal environment.
Conference Highlights:
- Updates on federal legislation, regulation, and enforcement
- State-level developments in legalization and regulation implementation
- Outlook for both medical marijuana and cannabinoid ingredients in foods, dietary supplements, and cosmetics
Call For Proposals
FDLI invites session proposals for its Legal and Practical Issues in Cannabis Regulation Conference. Topics should be at an advanced level and address timely and important issues related to cannabis legislation, regulation, compliance, enforcement, and litigation.
Guidelines
- Topics should be at an advanced level
- Topics that include a variety of perspectives and viewpoints, including government, industry, private attorneys, academics, and public interest are preferred.
- FDLI is committed to supporting, promoting, and celebrating diversity and inclusion in the food and drug law programs. To that end, proposals addressing systematic or historical impacts on health care disparity and racial equity in relation to all areas of the FDA-regulated community are strongly encouraged.
- We prefer submissions to include a reasonably detailed and thoughtful title for and description of the proposed session.
Proposal Reminders
- Multiple submissions from the same person or organization are welcome, but each proposal requires its own form.
- All submissions are treated as recommendations, and proposals may be modified or combined by FDLI to best suit the needs of the conference.
- All submissions are blinded before being reviewed by the Conference Planning Committee.
- All submissions must be received through the submission portal.
- Speaking opportunities are generally reserved for FDLI members.
Proposal Submission Timeline
- February 17: Call for Proposals closes.
- Early April: Those who submitted proposals will be notified of their submission’s status in April 2023.
Register by April 28!
Industry & Firms
- +$300 for non-members
- +$200 after 4/28/2023
Non-Profit
- +$100 for non-members
- +$100 after 4/28/2023
Government
- +$100 for non-members
- +$200 after 4/28/2023
Academic
- +$100 for non-members
- +$100 after 4/28/2023
Student
- students registration
- full-time students only
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Sponsors
Sponsorship opportunities are available. Please let us know if you would like more information.
Planning Committee
To be announced.